NFE2L2 and lung carcinoma: KEAP1 mutant lung cancer lost its inhibitory effect on NRF2, and when NRF2 is activated, it promotes the expression of FSP1, which inhibits ferroptosis by promoting the reduction of CoQ to CoQH2 (35).